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We present a case of a neonate with multiple atrial thrombi,
including a large pedunculated left atrial thrombus in the
setting of supraventricular tachycardia (SVT). Neonatal SVT
is common; however, atrial thrombus is a rare complication,
with only 2 previously reported cases in the literature.1,2 We
discuss the management of intra-atrial thrombus in this
setting.Case report
A 21-day-old female term neonate presented to a regional
hospital in New Zealand with a 2-day history of poor feeding
and jaundice. Antenatal period was unremarkable, including
no history of fetal tachycardia. At presentation, tachycardia
was noted and a 12-lead electrocardiogram conﬁrmed SVT at
a rate of 240 beats per minute (Figure 1). Cold water
immersions and adenosine boluses of up to 300 mcg/kg
produced a transient response; however, SVT persisted. An
intravenous amiodarone infusion was started and the baby
was air-transferred to our pediatric intensive care unit. The
rhythm was still SVT at a rate of 240 beats per minute on
arrival; therefore, oral digoxin was added at 5 mcg/kg daily
(half standard dose). A focused echocardiogram on arrival
demonstrated severe biventricular dysfunction (ejection
fraction 23%, fractional shortening 17%).
Eight hours after arrival, the rhythm reverted to sinus
rhythm. There was no pre-excitation on the 12-lead electro-
cardiogram (Figure 1). A complete echocardiogram to
reassess ventricular function and exclude structural heart
disease was performed on day 3 of admission in the pediatric
intensive care unit and revealed mobile hyperechoic massesKEYWORDS Neonates; Atrial thrombus; Supraventricular tachycardia;
Echocardiogram; Heparin
ABBREVIATIONS SVT ¼ supraventricular tachycardia
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(Figure 2). The heart was structurally normal other than a
small atrial septal defect with left-to-right-ﬂow. The largest
thrombus on echocardiogram measured 6  12 mm and
arose from the left atrial appendage. At least 2 smaller
thrombi were seen in the left atrium, one deeper in the left
atrial appendage measuring 5  3 mm and another on the
roof of the left atrium adjacent to the right-sided pulmonary
veins measuring 4  5 mm. A single thrombus was seen in
the right atrium superiorly, measuring 4  7 mm. The
systolic function had improved to moderate impairment by
this stage (ejection fraction 38%, fractional shortening 24%),
and clinically the infant was well, with no evidence of
systemic embolization.
After careful consideration and literature review, a
heparin infusion was commenced aiming for an activated
partial thromboplastin time of between 60 and 80 seconds.
A prothrombotic screen (including protein C, protein S,
antithrombin assay, anticardiolipin antibodies, and factor V
Leiden) was sent and was negative. The infant was closely
observed with careful echocardiographic follow-up. A repeat
echocardiogram on day 6 of admission demonstrated reso-
lution of atrial thrombi and normal systolic function (ejection
fraction 65%). There were no symptoms or clinical signs to
suggest embolization of thrombi speciﬁcally. After 3 days
the heparin infusion was changed to twice-daily subcuta-
neous enoxaparin with a plan to complete a 6-week course.
A further brief episode of SVT recurred on day 8, prompting
addition of oral propranolol to the treatment regimen. At
discharge, the infant was on amiodarone, propranolol, and
digoxin (digoxin levels within therapeutic range). She has
made good clinical progress with no breakthrough SVT on
therapy (including on 24-hour Holter monitor) and no
thrombi seen on the most recent echocardiogram 2 months
following presentation.Discussion
Intra-atrial thrombus is uncommon in neonates with struc-
turally normal hearts. When it does occur, it is most
commonly secondary to central venous access and arisespen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2015.10.006
KEY TEACHING POINTS
 Atrial thrombus is a rare complication of neonatal
supraventricular tachycardia (SVT), which is a
common neonatal arrhythmia.
 In cases of resistant or potentially long-standing
neonatal SVT, echocardiography may reveal
intracardiac thrombi.
 This case shows that atrial thrombi, even when very
large, may be treated successfully with
unfractionated heparin alone rather than with
thrombolytic agents or a surgical approach.
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history in our patient, who had a normal neonatal course withFigure 1 A: Electrocardiogram demonstrating supraventricular tachycardia at a
atrioventricular re-entrant tachycardia. B: A 12-lead electrocardiogram in sinus rhno requirement for central access lines. Unprovoked throm-
bus formation may be due to a primary thrombophilia;
however, in neonates this is uncommon.3
Intra-atrial thrombus can be seen in adult patients with
atrial arrhythmia, particularly atrial ﬂutter and atrial ﬁbrilla-
tion. The current guidelines from the American Heart
Association recommend anticoagulation in atrial ﬁbrillation
or atrial ﬂutter with hemodynamic instability where cardio-
version is planned.5 A recent paper by Schultz et al6
concludes that patients with SVT do not have the same
predisposing thrombogenic, endothelial, or inﬂammatory
factors to promote or initiate thrombus formation as patients
with atrial ﬁbrillation.
Following the unexpected ﬁnding on echocardiogram of
atrial thrombi in our case, various treatment options were
considered. Thrombolysis was felt to present a higher chance
of fragmentation and systemic embolization. In addition torate of 234 beats per minute. There are retrograde P waves consistent with
ythm at a rate of 120 beats per minute with no evidence of pre-excitation.
Figure 2 A: Apical 4-chamber view showing main thrombus arising from the left atrial appendage and isolated thrombus attached at the roof of the right
atrium. B: Apical 4-chamber view showing small thrombus adjacent to the right pulmonary veins in the left atrium. C: Parasternal short-axis view showing main
thrombus at the base of the left atrial appendage and separate thrombus deep in the left atrial appendage.
73Mitchelson et al Multiple Atrial Thrombithis, there is a paucity of data on the use of thrombolysis in
neonates, with no therapeutic range for safe and effective
use.4 Surgical removal of the main thrombus was also
considered, as the thrombus was large and had a concerning
mobility; however, there were concerns at the invasiveness
of this approach, with no guarantee of avoiding systemic
embolization.
We found 2 previous case reports of neonatal SVT
complicated by left atrial thrombus managed with low-
molecular-weight heparin (enoxaparin) for initial treatment.
The ﬁrst report1 combined enoxaparin with sotalol as an
antiarrhythmic owing to the pre-excitation mechanism
behind the initial SVT. Thrombus resolution was seen at 5
weeks, at which stage enoxaparin was discontinued. The
more recent case report2 also included aspirin and warfarin in
addition to enoxaparin owing to low protein C and protein S
levels on a thrombophilia screen. Thrombus resolution was
noted on echocardiogram follow-up at 6 months. As
described, our patient had a normal thrombophilia screen.
Resolution of thrombus in our patient was achieved with
unfractionated heparin. The infusion rate was governed by
the patient’s activated partial thromboplastin time, aiming for
1.5–2 times the upper limits of normal. This is in keeping
with current recommendations for use of antithrombotic
agents in neonates and children.7 Within 5 days, the thrombi
had resolved on echocardiography. In keeping with the
recommendations, we elected for a total 6-week course of
therapy, changing to enoxaparin, for ease of administration
(subcutaneous versus intravenous), and with less frequent
monitoring with a less narrow therapeutic index.Conclusion
We report a rare case of intra-atrial thrombi in an infant with
resistant SVT that was successfully managed with intra-
venous heparin. Although thrombolysis and surgical inter-
vention for a large pedunculated left atrial thrombus were
considered, intravenous heparin achieved therapeutic suc-
cess without complications and we recommend that this
strategy be considered in similar circumstances.References
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